Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.
J&J tackles medical illustration inequity with free database of diverse images
Johnson & Johnson wants to change the status quo in medical illustrations with more Black, brown and indigenous depictions. Its “Illustrate Change” campaign is centered
July 4, 2023